Neogen Chemicals posted strong Q2 FY27 results with consolidated revenue rising to Rs 295.96 crore and net profit reaching Rs 8.23 crore. The board approved a Rs 45 crore capacity expansion at its Telangana facility, targeting an additional Rs 150-200 crore in annual revenue. The firm also plans early redemption of Rs 200 crore in NCDs amid ongoing monitoring of credit ratings and insurance recovery from a prior plant incident.
Neogen Chemicals Q2 Profit Growth and Expansion Plans
Standalone Revenue for Q2 FY27 hit Rs 288 crore, while consolidated net profit surged to Rs 8.23 crore.
Reader Takeaway: Robust revenue growth and strategic capacity expansion signal demand, balanced by credit rating pressures and insurance recovery monitoring.
What just happened
Neogen Chemicals reported a significant year-on-year increase in profitability for the quarter ended September 30, 2026. Alongside the financial results, the board greenlit an expansion project at the Patancheru plant in Telangana, doubling Organo-Lithium production capacity to 600 MT per annum with a Rs 45 crore investment. The company also announced the voluntary early redemption of Rs 200 crore in Non-Convertible Debentures (NCDs).
Why this matters
The capacity expansion demonstrates management's confidence in long-term demand, with expected revenue generation of up to Rs 200 crore from the new facility. Investors should note the company's deleveraging efforts through early debt repayment, even as it manages higher interest costs following a credit rating adjustment.
Risks to watch
CRISIL downgraded the company’s long-term credit rating to 'A-/Negative' in July 2026, which lifted the coupon rate on its NCDs to 11%. Additionally, the firm is awaiting the full recovery of a Rs 171.52 crore insurance claim related to the March 2025 fire incident at its Dahej plant. Management maintains that this amount remains fully recoverable.
Corporate Governance
The company has initiated a postal ballot for shareholder approval regarding material related-party transactions with subsidiaries Neogen Ionics and Neogen Morita New Materials. These transactions involve operational support, guarantees, and infrastructure sharing capped at Rs 500 crore, ensuring inter-company resource optimization.
What to track next
Watch for the completion timeline of the Patancheru facility by the end of next fiscal year and any further updates on the insurance claim settlement process from the Dahej site.